Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Bierings

Showing results (91-100 of 94) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 94 results.
The Lancet. Haematology|October 18, 2016
Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysisImke H Bartelink, Arief Lalmohamed, Elisabeth M L van Reij, et al.
Eclinicalmedicine|December 28, 2023
Influence of invasive aspergillosis during acute leukaemia treatment on survival after allogeneic stem cell transplantation: a prospective study of the EBMT Infectious Diseases Working PartyOlaf Penack, Gloria Tridello, Urpu Salmenniemi, et al.
Bone Marrow Transplantation|March 24, 2020
Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?-A multicenter EBMT-PDWP studyAndre Manfred Willasch, Christina Peters, Petr Sedláček, et al.
Bone Marrow Transplantation|August 20, 2021
Correction: Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?-A multicenter EBMT-PDWP studyAndre Manfred Willasch, Christina Peters, Petr Sedláček, et al.
Pageof 10

Showing results (91-100 of 94) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 94 results.
The Lancet. Haematology|October 18, 2016
Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysisImke H Bartelink, Arief Lalmohamed, Elisabeth M L van Reij, et al.
Eclinicalmedicine|December 28, 2023
Influence of invasive aspergillosis during acute leukaemia treatment on survival after allogeneic stem cell transplantation: a prospective study of the EBMT Infectious Diseases Working PartyOlaf Penack, Gloria Tridello, Urpu Salmenniemi, et al.
Bone Marrow Transplantation|March 24, 2020
Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?-A multicenter EBMT-PDWP studyAndre Manfred Willasch, Christina Peters, Petr Sedláček, et al.
Bone Marrow Transplantation|August 20, 2021
Correction: Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?-A multicenter EBMT-PDWP studyAndre Manfred Willasch, Christina Peters, Petr Sedláček, et al.
Pageof 10